Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-013617

Director sold 425 shares at $214.92 ($91,341)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Drexler Karen Director 2024-04-29 Sale −425 $214.92 $91,341 8,446 D: show line 1 in the form
Open-market sales · 425 sh · avg $214.92 · $91,341
Loading xslF345X05/form4.xml…